ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3015

Characterization of the Profibrotic/Antifibrotic Profile of microRNA Contained in Exosomes Isolated from Cultured Normal Human Dermal and Lung Microvascular Endothelial Cells Undergoing Endothelial Mesenchymal Transition in Vitro

Sergio A. Jimenez1, Sonsoles Piera-Velazquez2, Peter J. Wermuth3 and Kerri Fasino4, 1Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA, 2Jefferson Institute of Molecular Medicine, Thomas Jefferson Univ, Philadelphia, PA, 3Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center, Thomas Jefferson University, Philadelphia, PA, 4Jefferson Institute of Molecular Medicine and Division of Connective Tissue Diseases, Thomas Jefferson University, Philadelphia, PA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: endothelial cells, fibrosis and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Sclerosis (SSc) is characterized by progressive
fibrosis of skin and multiple internal organs, severe alterations in the
microvasculature, and numerous immunological abnormalities. Recently it has
been suggested that endothelial to mesenchymal transition (EndoMT) may be involved
in SSc vasculopathy and tissue fibrosis. Exosomes are 30-150 nm lipid bilayer
bound microvesicles released from all human cells into their surrounding
intercellular space and into the circulation and contain numerous
macromolecules including mRNAs, miRNAs, proteins, cytokines, chemokines and
growth factors. Exosomes are capable of carrying complex signals to sites
removed from the cell of origin. We propose that EndoMT-activated EC induce
phenotypic changes in normal/healthy fibroblasts and EC and that these effects
are mediated by exosomes released into the circulation that reach normal
fibroblasts and EC, fusing with them, and transferring their miRNA contents
rendering them profibrotic. We examined here whether exosomes isolated from Endo-MT-activated
normal human dermal and lung microvascular EC display alterations in their
miRNA content that may be capable of inducing a profibrotic phenotype in normal
fibroblasts and EC.

Methods:
Normal human dermal or lung microvascular EC were expanded in monolayer
cultures until reaching confluency, then they were cultured under control
conditions or in the presence of 10 ng/ml of TGF-β1 or TGF-β2 for 48h
to induce EndoMT. Following treatment the cells were washed and incubated in
exosome-free culture media for additional 24h. The culture media were collected
and exosomes were isolated using the ExoQuick polymer exosome purification
procedure. The exosomes were pelleted by centrifugation.  Exosome miRNA were
isolated by lysis of the pellet and RNA purification using SeraMir RNA spin
columns. cDNA was synthesized by polyadenlyation of RNA followed by reverse
transcription substituting a miRNA 3′ adaptor oligonucleotide in place of
Oligo-dT. The resulting single-stranded miRNA-derived cDNA was utilized in qPCR
profiling of profibrotic and antifibrotic miRNAs.  Exosomal miRNA levels were
normalized to levels of the small nucleolar RNA SNORD25.

Results:
Exosomes were successfully isolated from culture media samples and sufficient
RNA was extracted for RTPCR performance and relative miRNA quantification. The
quantification of profibrotic and antifibrotic miRNA in the exosomes isolated
from the culture media of both cell types is shown in Figure 1.

Conclusion: Exosomes
were successfully isolated and purified from the culture media of human
EC. TGF-β1 or TGF-β2-mediated in vitro induction of EndoMT in
normal human dermal or lung microvascular EC resulted in a marked increase in
profibrotic miRNA and a marked decrease in antifibrotic miRNA contained in
exosomes released by these cells into the culture media.


Disclosure: S. A. Jimenez, None; S. Piera-Velazquez, None; P. J. Wermuth, None; K. Fasino, None.

To cite this abstract in AMA style:

Jimenez SA, Piera-Velazquez S, Wermuth PJ, Fasino K. Characterization of the Profibrotic/Antifibrotic Profile of microRNA Contained in Exosomes Isolated from Cultured Normal Human Dermal and Lung Microvascular Endothelial Cells Undergoing Endothelial Mesenchymal Transition in Vitro [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/characterization-of-the-profibroticantifibrotic-profile-of-microrna-contained-in-exosomes-isolated-from-cultured-normal-human-dermal-and-lung-microvascular-endothelial-cells-undergoing-endothelial-me/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-the-profibroticantifibrotic-profile-of-microrna-contained-in-exosomes-isolated-from-cultured-normal-human-dermal-and-lung-microvascular-endothelial-cells-undergoing-endothelial-me/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology